UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in TGTX — Tg Therapeutics, Inc.
CIK 861177
NEW YORK, NY
Position in TGTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$13,694,121
+$5,871,579 QoQ
Shares Held
249,256
+5.9% QoQ
Ownership
0.163%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 426 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 57%
Shared 0%
None 43%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. TGTX ranks #35 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in TGTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,694,121 | 249,256 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $7,822,542 | 235,477 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $7,115,226 | 238,686 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $8,852,464 | 245,051 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,734,050 | 409,393 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $11,318,732 | 287,059 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $8,198,333 | 272,370 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,874,950 | 293,927 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,726,134 | 321,874 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,462,908 | 161,927 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,765,711 | 161,927 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,353,707 | 161,927 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,331,589 | 134,122 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,017,193 | 134,122 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,845,158 | 155,973 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $838,145 | 141,579 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $624,974 | 147,053 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,387,327 | 145,881 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,206,736 | 116,144 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,962,912 | 119,078 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,357,783 | 112,343 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $4,983,252 | 103,387 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $29,686,615 | 570,677 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $17,204,885 | 642,933 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $13,183,127 | 676,752 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $6,516,008 | 662,196 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||